Renee Hart

Company: LumaCyte

Job title: President & CBO

Seminars:

Quantitative Cellular PAT Analytics Driving Improvements in Advanced Therapy Process and Production Outcomes 9:00 am

Label-free analysis of intrinsic biochemical and biophysical properties of cells provides real-time insights into cellular changes occurring throughout a manufacturing process. Additionally, ensuring robust cellular fitness of starting material is a crucial component to manufacturing and treatment success Learn how Laser Force Cytology™, a label-free, quantitative precision PAT enables real-time monitoring of CQAs and CPPs…Read more

day: Day One

Panel Discussion: Optimizing PAT Transition from Early Development to Clinical Phases 9:30 am

Utilizing PAT tools in the development phase to optimize processes and improve process understanding, paving the way for effective clinical GMP (Good Manufacturing Practice) implementation Addressing and mitigating process developers’ reluctance to monitor processes during manufacturing, ensuring the timely and efficient deployment of PAT tools Implementing strategies to expedite the transition from development to clinical…Read more

day: Day One